A Randomized, Double-Blind, Placebo Controlled Multicenter Study To Evaluate the Efficacy of a Humanized Interleukin-9 Monoclonal Antibody (MEDI-528) on the Late Asthmatic Response in Adults with Atopic Asthma Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • January 1, 2009